HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New Phthalates Study Links Kids' Behavior Problems To Moms' Cosmetics Use

This article was originally published in The Rose Sheet

Executive Summary

A new study exploring a possible link between phthalates exposure in the womb and childhood behavioral problems suggests that regulations need to be in place to limit the chemicals' use in personal-care products, according to investigators

You may also be interested in...



Council, Campaign Vie For Influence In Washington: Top Stories Of 2010

Developments in the natural/organic marketplace, FDA's pending sunscreen monograph, the regulatory fate of controversial cosmetic ingredients and the larger question of how the personal-care industry should be policed drove interest among manufacturers and stakeholders in 2010.

Council, Campaign Vie For Influence In Washington: Top Stories Of 2010

Developments in the natural/organic marketplace, FDA's pending sunscreen monograph, the regulatory fate of controversial cosmetic ingredients and the larger question of how the personal-care industry should be policed drove interest among manufacturers and stakeholders in 2010.

EPA Action Plan For Phthalates Could Lead To Restrictions In 2012

The Environmental Protection Agency has issued an action plan for eight phthalates, including two used in cosmetics, which could lay the groundwork for a large-scale ban of the substances in 2012

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016733

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel